Lyfebulb

Every multiple sclerosis (MS) patient has a different experience, and understanding these experiences is imperative for effectively treating all patients. Which symptoms of MS can now be treated, which should be targeted next, and how do we move from treatments to cures? Join Tim Coetzee PhD (Chief Advocacy, Services and Science Officer, National Multiple Sclerosis Society), Valentina Fossati, PhD (Senior Research Investigator, The The New York Stem Cell Foundation Research Institute ), Teresa Wright-Johnson (Lyfebulb Patient Ambassador), and Karin Hehenberger, MD, PhD (Founder & CEO, Lyfebulb) for a discussion about how patient voices can inform MS research and its road to better treatments and cures. The discussion will be moderated by NYSCF’s Raeka Aiyar, PhD. https://buff.ly/3197kzf

Note that not all disability policies are the same, which is why it is important to obtain a copy of your plan documents before you need to apply for the benefits.

Thank you to all of the doctors doing what they love to help so many living with a chronic illness. #DoctorsDay2021 #Lyfebulb #ChronicIllness

Hope you join this chat hosted by The New York Stem Cell Foundation Research Institute. Looking forward to a great conversation. Karin Hehenberger Teresa Wright-Johnson

If you missed the chat with Stupid Dumb Breast Cancer and Stacy Hurt - Advocate / Speaker / Consultant check it out! It is Colon Cancer Awareness Month and this conversation talks about what you can do to help spread real awareness. https://fb.watch/4sw2JxwkgV/

Recovery does not look the same for everyone. Learning new skills to help you on this road are key to survival. Join Karin as she moderates a chat with AnnMarie and Avery and they discuss their own paths to recovery. Meet us on Facebook, YouTube or Twitter at 4pm ET #RecoveryLyfe

"Lyfebulb is a patient engagement platform with the mission of reducing the burden of living with chronic disease through the power of the patient." Says CEO Karin in her interview with Lucinda Roberts

"I am excited to publicly announce the launch of #TransplantLyfe: a place where transplant recipients, donors, care partners and those waiting for a transplant can connect and learn from one another. This launch is extremely personal to me, for obvious reasons, and connecting patients to other patients has been fundamental to our mission since I co-founded Lyfebulb in 2014." https://buff.ly/2NEqTfx #jointransplantlyfe

Living with a transplant can bring on many issues, finding a solution is a game changer. Join our CEO Karin and Amanda a transplant thriver as they talk solutions.

Gradually, Karin says, I understood that patients can be innovators. We know the problems. We can have solutions. Read more and connect with https://buff.ly/3qR82MA

"CSL Behring is proud to partner in the development and launch of TransplantLyfe a critical tool that can directly help provide support to patients and their care team," said Kevin Kovaleski, Vice President, Global Commercial Development, Transplant, CSL Behring. "The opportunity to be a part of changing the way that transplantation is managed and cared for is one that closely aligns with delivering on our promise to address unmet needs in the transplant community." Karin Hehenberger #jointransplantlyfe CSL Behring